BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24357625)

  • 1. Fluorescent biosensors for high throughput screening of protein kinase inhibitors.
    Prével C; Pellerano M; Van TN; Morris MC
    Biotechnol J; 2014 Feb; 9(2):253-65. PubMed ID: 24357625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
    Prével C; Kurzawa L; Van TN; Morris MC
    Eur J Med Chem; 2014 Dec; 88():74-88. PubMed ID: 25314935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent sensors of protein kinases: from basics to biomedical applications.
    Nhu Ngoc Van T; Morris MC
    Prog Mol Biol Transl Sci; 2013; 113():217-74. PubMed ID: 23244792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
    Morris MC
    Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
    Heeres JT; Hergenrother PJ
    Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent-protein biosensors: new tools for drug discovery.
    Giuliano KA; Taylor DL
    Trends Biotechnol; 1998 Mar; 16(3):135-40. PubMed ID: 9523461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
    Simard JR; Rauh D
    Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors.
    Uri A; Lust M; Vaasa A; Lavogina D; Viht K; Enkvist E
    Biochim Biophys Acta; 2010 Mar; 1804(3):541-6. PubMed ID: 19879386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease.
    Honarnejad K; Kirsch AK; Daschner A; Szybinska A; Kuznicki J; Herms J
    J Biomol Screen; 2013 Dec; 18(10):1309-20. PubMed ID: 24221842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes.
    Morris MC
    Cell Biochem Biophys; 2010; 56(1):19-37. PubMed ID: 19921468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations.
    Simard JR; Rauh D
    Methods Enzymol; 2014; 548():147-71. PubMed ID: 25399645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-resolved Förster resonance energy transfer-based technologies to investigate G protein-coupled receptor machinery: high-throughput screening assays and future development.
    Scholler P; Zwier JM; Trinquet E; Rondard P; Pin JP; Prézeau L; Kniazeff J
    Prog Mol Biol Transl Sci; 2013; 113():275-312. PubMed ID: 23244793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a genetically encoded biosensor for cyclin B1-cyclin dependent kinase 1.
    Belal AS; Sell BR; Hoi H; Davidson MW; Campbell RE
    Mol Biosyst; 2014 Feb; 10(2):191-5. PubMed ID: 24281384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displaced by Deceivers: Prevention of Biosensor Cross-Talk Is Pivotal for Successful Biosensor-Based High-Throughput Screening Campaigns.
    Flachbart LK; Sokolowsky S; Marienhagen J
    ACS Synth Biol; 2019 Aug; 8(8):1847-1857. PubMed ID: 31268296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.